UDHAN KUMAR CHORDIA

      DIN: 03334633

      For latest information about the director, visit MCA.

      UDHAN KUMAR CHORDIA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 03334633. UDHAN KUMAR CHORDIA is/has been associated with 21 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      AGMA HEALTH FOODS AND MERCHANDISING LLP Designated Partner 16-Nov-2015
      ALTIOUSS DEVELOPERS LLP Designated Partner 18-Nov-2015
      PROVIDUS CONSULTING LLP Designated Partner 06-Feb-2017
      ACHORD AGGRO PRIVATE LIMITED Director 06-Jun-2018
      MEDOPHARM PRIVATE LIMITED Managing Director 10-Aug-2020
      AGMA HEALTH FOODS AND MERCHANDISING PRIVATE LIMITED Director 23-Apr-2021
      AGMA PACKAGING PRIVATE LIMITED Director 30-Nov-2021
      NIVARAM PHARMA PRIVATE LIMITED Director 30-Nov-2021
      GANILK PRIVATE LIMITED Director 04-Dec-2018
      ALTIOUS VENTURES CONSTRUCTIONS PRIVATE LIMITED Director 04-Jan-2011
      LEKTRIFY TECHNOLOGIES PRIVATE LIMITED Director 02-Nov-2016
      MEDOPHARM WELLNESS PRIVATE LIMITED Director 30-Dec-2002

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      P G FOILS LIMITED Additional Director 21-Mar-2009 29-Sep-2009
      P G FOILS LIMITED Director 29-Sep-2009 05-Dec-2018
      MEDOPHARM PRIVATE LIMITED Additional Director 10-Aug-2020 10-Aug-2020
      AGMA PACKAGING PRIVATE LIMITED Additional Director 01-Jun-2021 30-Nov-2021
      NIVARAM PHARMA PRIVATE LIMITED Additional Director 01-Jun-2021 30-Nov-2021
      GLOSEL INDIA IMPEX PRIVATE LIMITED Director 18-Nov-2002 30-Sep-2018
      ZENARA PHARMA PRIVATE LIMITED Director 18-Mar-2004 06-Dec-2007
      TABLETS MEDOPHARM PRIVATE LIMITED Additional Director 06-Aug-2019 01-Nov-2019
      ANGAN INVESTMENT AND MANAGEMENT PRIVATE LIMITED Additional Director 16-Feb-2022 11-May-2022

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales